Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren's syndrome and Sjögren-associated non-Hodgkin lymphomas and is regulated by IL-18
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren's syndrome and Sjögren-associated non-Hodgkin lymphomas and is regulated by IL-18
Authors
Keywords
-
Journal
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
Volume 181, Issue 2, Pages 219-229
Publisher
Wiley
Online
2015-04-16
DOI
10.1111/cei.12643
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of the IL-22/IL-22R1 axis in cancer
- (2014) Chrissie Lim et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Interleukin 22 Signaling Promotes Cell Growth in Mantle Cell Lymphoma
- (2014) Pascal Gelebart et al. Translational Oncology
- Primary Sjögren's syndrome and malignancy risk: a systematic review and meta-analysis
- (2013) Yan Liang et al. ANNALS OF THE RHEUMATIC DISEASES
- IL-22, not simply a Th17 cytokine
- (2013) Sascha Rutz et al. IMMUNOLOGICAL REVIEWS
- The P2X7receptor-inflammasome complex has a role in modulating the inflammatory response in primary Sjögren's syndrome
- (2013) C. Baldini et al. JOURNAL OF INTERNAL MEDICINE
- Interleukin-18 and IL-18 Binding Protein
- (2013) Charles A. Dinarello et al. Frontiers in Immunology
- Interleukin 22-producing CD4+ T cells in malignant pleural effusion
- (2012) Zhi-Jian Ye et al. CANCER LETTERS
- Pro-tumour activity of interleukin-22 in HPAFII human pancreatic cancer cells
- (2012) L. M. Curd et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine
- (2012) Samuel Huber et al. NATURE
- Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjögren's syndrome
- (2011) Francesco Ciccia et al. ANNALS OF THE RHEUMATIC DISEASES
- IL-22, but Not IL-17, Dominant Environment in Cutaneous T-cell Lymphoma
- (2011) T. Miyagaki et al. CLINICAL CANCER RESEARCH
- Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3
- (2011) Runqiu Jiang et al. HEPATOLOGY
- IL-23 Is Required for Long-Term Control of Mycobacterium tuberculosis and B Cell Follicle Formation in the Infected Lung
- (2011) Shabaana A. Khader et al. JOURNAL OF IMMUNOLOGY
- Susceptibility of patients with rheumatic diseases to B-cell non-Hodgkin lymphoma
- (2011) Catarina Dias et al. Nature Reviews Rheumatology
- Expression of Interleukin-22 in Sjögren’s Syndrome: Significant Correlation with Disease Parameters
- (2011) T. N. Lavoie et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Cytokines in Sjogren's syndrome: potential therapeutic targets
- (2010) N. Roescher et al. ANNALS OF THE RHEUMATIC DISEASES
- A novel role for IL-22R1 as a driver of inflammation
- (2010) R. Savan et al. BLOOD
- Characteristics of the minor salivary gland infiltrates in Sjögren's syndrome
- (2009) Maria I. Christodoulou et al. JOURNAL OF AUTOIMMUNITY
- Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenicity in ALK+ anaplastic large cell lymphoma
- (2008) J Dien Bard et al. LEUKEMIA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More